Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,705 | -34,728 | -21,426 | -52,448 | -42,369 |
| Depreciation Amortization | 2,907 | 2,240 | 1,586 | 6,226 | 4,426 |
| Accounts payable and accrued liabilities | -3,524 | -4,084 | -1,944 | 3,193 | 5,168 |
| Other Working Capital | -12,894 | -11,468 | -10,565 | -9,781 | -4,830 |
| Other Operating Activity | 16,265 | 14,780 | 11,243 | 5,052 | 3,826 |
| Operating Cash Flow | $-45,951 | $-33,260 | $-21,106 | $-47,758 | $-33,779 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,444 | -3,418 | -985 | -6,477 | -2,672 |
| Other Investing Activity | 75 | 75 | 75 | 75 | 75 |
| Investing Cash Flow | $-5,369 | $-3,343 | $-910 | $-6,402 | $-2,597 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,750 | 6,750 | 6,750 | 21,903 | N/A |
| Debt Repayment | -6,376 | -4,172 | -2,044 | -8,576 | -6,452 |
| Common Stock Issued | 235,956 | 234,857 | 102,687 | 18 | 7 |
| Other Financing Activity | -1,438 | -1,438 | -1,438 | 40,646 | 40,647 |
| Financing Cash Flow | $234,892 | $235,997 | $105,955 | $53,991 | $34,202 |
| Beginning Cash Position | 3,914 | 3,914 | 3,914 | 4,083 | 4,083 |
| End Cash Position | 187,486 | 203,308 | 87,853 | 3,914 | 1,909 |
| Net Cash Flow | $183,572 | $199,394 | $83,939 | $-169 | $-2,174 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,951 | -33,260 | -21,106 | -47,758 | -33,779 |
| Capital Expenditure | -5,444 | -3,418 | -985 | -6,477 | -2,672 |
| Free Cash Flow | -51,395 | -36,678 | -22,091 | -54,235 | -36,451 |